Viewing Study NCT04958993


Ignite Creation Date: 2025-12-25 @ 1:17 AM
Ignite Modification Date: 2026-01-06 @ 9:54 PM
Study NCT ID: NCT04958993
Status: TERMINATED
Last Update Posted: 2022-02-25
First Post: 2020-08-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of Anlotinib Combined With Concurrent Chemoradiotherapy in Patients With Unresectable Stage III Non-small Cell Lung Cancer
Sponsor:
Organization: